lapachol has been researched along with Carcinoma 256, Walker in 1 studies
lapachol : A hydroxy-1,4-naphthoquinone that is 1,4-naphthoquinone substituted by hydroxy and 3-methylbut-2-en-1-yl groups at positions 2 and 3, respectively. It is a natural compound that exhibits antibacterial and anticancer properties, first isolated in 1882 from the bark of Tabebuia avellanedae.
Carcinoma 256, Walker: A transplantable carcinoma of the rat that originally appeared spontaneously in the mammary gland of a pregnant albino rat, and which now resembles a carcinoma in young transplants and a sarcoma in older transplants. (Stedman, 25th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| da Consolação, M | 1 |
| Linardi, F | 1 |
| de Oliveira, MM | 1 |
| Sampaio, MR | 1 |
1 other study available for lapachol and Carcinoma 256, Walker
| Article | Year |
|---|---|
A lapachol derivative active against mouse lymphocytic leukemia P-388.
Topics: Animals; Antineoplastic Agents; Carcinoma 256, Walker; Leukemia, Experimental; Mice; Mice, Inbred C5 | 1975 |